SRRK Stock Analysis: Buy, Sell, or Hold?
SRRK - Scholar Rock Holding Corporation Common Stock
$51.27
2.08 (4.23%)
▲
5d:
+11.65%
30d:
+7.44%
90d:
+17.43%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When SRRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SRRK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SRRK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SRRK is currently trading at $51.27, which is considered extended relative to its 30-day fair value range of $44.80 to $49.41.
Technical Outlook: Technically, SRRK is in a uptrend. The price is approaching resistance at $51.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: SRRK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $59.31 (+15.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRRK is in a uptrend. The price is approaching resistance at $51.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: SRRK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $59.31 (+15.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$44.80 -
$49.41
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
65.8%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading below Wall St target ($59.31)
Trading Range Analysis
30-Day Trading Range
$44.80 -
$49.41
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$43.23
Resistance Level
$51.64
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-20.09
Wall Street Target
$59.31
(+15.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 24, 2026 7:13 AM ET
Data refreshes hourly during market hours. Next update: 8:13 AM
Data refreshes hourly during market hours. Next update: 8:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRRK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
David Hallal
SELL
30615 shares
2026-04-16
Keith Woods
SELL
10220 shares
2026-04-16
Vikas Sinha
SELL
10410 shares
2026-04-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 60 BUY |
Advanced SRRK Option Strategies
Professional options setups generated by AI based on today's SRRK price and gamma walls.
